LEADER 01433nam  2200433 a 450 
001 9910699558803321
005 20230902161726.0
035   $a(CKB)5470000002403337
035   $a(OCoLC)745447267
035   $a(EXLCZ)995470000002403337
100   $a20110805d2004      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$a5-MeO-AMT$b[electronic resource]
210  1$aJohnstown, PA :$cU.S. Dept. of Justice, National Drug Intelligence Center,$d[2004]
215   $a1 online resource (2 unnumbered pages) $ccolor illustrations
225 1 $aFast facts
225 1 $aQuestions and answers
300   $aTitle from title screen (viewed on Aug 5, 2011).
300   $a"NDIC product no. 2004-L0559-002."
410  0$aFast facts (National Drug Intelligence Center (U.S.))
410  0$aQuestions and answers (National Drug Intelligence Center (U.S.))
517 3 $aFive-methoxy-alphamethyltryptamine
606   $aTryptamine$zUnited States
606   $aHallucinogenic drugs$zUnited States
606   $aDrug abuse$zUnited States
615  0$aTryptamine
615  0$aHallucinogenic drugs
615  0$aDrug abuse
712 02$aNational Drug Intelligence Center (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699558803321
996   $a5-MeO-AMT$93140563
997   $aUNINA